⚜️LORD MEDZ MARKET DISPATCH⚜️
Goldbach Pathway – Algo 2 Execution in Motion
Pair: RSR/USDT
Timeframe: 1W
Update Date: 9th April 2025
"The seed planted in silence grows unseen—until it bursts through the surface to shock the world."
— Lord MEDZ
After months of quiet accumulation and subtle liquidity harvesting beneath key OB zones, RSR now stands at the critical juncture of its Goldbach Pathway, aligned with Algo 2 mechanics. As we follow the orchestrated sequence of the algo, the chart reveals the early ignition of the next macro impulse wave—one that seeks to fulfill its programmed trajectory to Goldbach 89.
🧬 Goldbach Algo 2 Update:
Entry Zone activated just above the Order Block at 0.0036–0.0042.
Price Rejection and absorption seen near 0.0075–0.0080 range, typical of initial liquidity sweeps.
First validation pulse confirmed with a breakout candle on the weekly close above structure.
Current positioning aligns with prior LV (Liquidity Void) re-entry.
📈 Projected Move:
Target: 0.065–0.070 zone
Projected ROI: +916%
Path completion aligns with previous Fair Value Gap (FV) + Break Block Retest around the 0.058–0.071 range.
This is no random pump—Algo 2’s magnet is pulling with precision. The entire structure shows confluence between imbalance fills, FVG targeting, and a path paved long before this accumulation began.
🧿 Key Observations:
🟢 OB Retest respected.
🧊 Long-term support held with surgical accuracy.
📉 Bearish liquidity has been harvested—bullish algorithm engaged.
🎯 If the path completes as anticipated, Goldbach 89 will mark the final distribution zone.
Conclusion:
The realm of RSR has awakened. The coded destiny of this asset is now uncoiling, and those attuned to the rhythm of Algo 2 shall ride this wave to its destined apex.
This is not financial advice.
This is an echo from the chambers of algorithmic prophecy.
Observe. Align. Ascend.
— Lord MEDZ
Goldbach Pathway – Algo 2 Execution in Motion
Pair: RSR/USDT
Timeframe: 1W
Update Date: 9th April 2025
"The seed planted in silence grows unseen—until it bursts through the surface to shock the world."
— Lord MEDZ
After months of quiet accumulation and subtle liquidity harvesting beneath key OB zones, RSR now stands at the critical juncture of its Goldbach Pathway, aligned with Algo 2 mechanics. As we follow the orchestrated sequence of the algo, the chart reveals the early ignition of the next macro impulse wave—one that seeks to fulfill its programmed trajectory to Goldbach 89.
🧬 Goldbach Algo 2 Update:
Entry Zone activated just above the Order Block at 0.0036–0.0042.
Price Rejection and absorption seen near 0.0075–0.0080 range, typical of initial liquidity sweeps.
First validation pulse confirmed with a breakout candle on the weekly close above structure.
Current positioning aligns with prior LV (Liquidity Void) re-entry.
📈 Projected Move:
Target: 0.065–0.070 zone
Projected ROI: +916%
Path completion aligns with previous Fair Value Gap (FV) + Break Block Retest around the 0.058–0.071 range.
This is no random pump—Algo 2’s magnet is pulling with precision. The entire structure shows confluence between imbalance fills, FVG targeting, and a path paved long before this accumulation began.
🧿 Key Observations:
🟢 OB Retest respected.
🧊 Long-term support held with surgical accuracy.
📉 Bearish liquidity has been harvested—bullish algorithm engaged.
🎯 If the path completes as anticipated, Goldbach 89 will mark the final distribution zone.
Conclusion:
The realm of RSR has awakened. The coded destiny of this asset is now uncoiling, and those attuned to the rhythm of Algo 2 shall ride this wave to its destined apex.
This is not financial advice.
This is an echo from the chambers of algorithmic prophecy.
Observe. Align. Ascend.
— Lord MEDZ
Lord MEDZ
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Lord MEDZ
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.